Dyne Therapeutics (DYN)
(Delayed Data from NSDQ)
$36.41 USD
+2.07 (6.03%)
Updated Sep 19, 2024 04:00 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Dyne Therapeutics, Inc. [DYN]
Reports for Purchase
Showing records 1 - 20 ( 22 total )
Company: Dyne Therapeutics, Inc.
Industry: Medical - Drugs
FSHD and Pompe Programs Add Force to Dyne?s Pipeline; PT Up to $55
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Dyne Therapeutics, Inc.
Industry: Medical - Drugs
New Biomarker Data Supports Potential Accelerated Approvals for DYNE-101 and DYNE-251; PT to $48
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Dyne Therapeutics, Inc.
Industry: Medical - Drugs
ACHIEVE?s Myotonia Data is Impressive Despite Low Dose
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Dyne Therapeutics, Inc.
Industry: Medical - Drugs
Dyne?s Strength in the Long Run Lies in the Differentiated Platform
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Dyne Therapeutics, Inc.
Industry: Medical - Drugs
Company: Dyne Therapeutics, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for DYN 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Dyne Therapeutics, Inc.
Industry: Medical - Drugs
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Utilities- U.S.-M-A Activity Update-Consolidation Powers UpThis report contains brief updates on the following: ALE, LNT, AT, AVA, BKH, EE, EDE, GXP, IDA, ITC, MDU, MGEE, OGE, OTTR, PNW, PNM, POR, SCG, UTL, WR, ATO, CPK, CNIG, DGAS, EGAS, NFG, NJR, NI, NWN, OGS, STR, RGCO, SJI, SWX, VVC, WGL, ABY, NEP, NYLD, PEGI, TERP, CPN, DYN, NRG, TLN. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: G.RESEARCH, LLC
Analyst: WINTER T
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Due to analyst departure, we are dropping coverage of the following stocks:
Provider: Drexel Hamilton, LLC
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Ameren Asset?s Liquidity Offers Long-Dated Option on Market Recovery
Provider: Drexel Hamilton, LLC
Analyst: SMITH A
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Best Leverage to the Cycle; Initiating Coverage with a Buy Rating
Provider: Drexel Hamilton, LLC
Analyst: SMITH A
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Company: Dyne Therapeutics, Inc.
Industry: Utility - Electric Power
Merger and Acquisitions.
Provider: WALL STREET ACCESS CORP.